Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1961 1
1974 2
1975 2
1976 1
1977 3
1978 3
1979 11
1980 10
1981 7
1982 7
1983 10
1984 9
1985 8
1986 8
1987 7
1988 6
1989 6
1990 6
1991 7
1992 10
1993 8
1994 4
1995 4
1996 3
1997 3
1998 1
1999 6
2000 2
2001 3
2002 3
2003 2
2005 1
2006 1
2009 1
2010 3
2012 1
2014 1
2018 1
2020 1
2021 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
Diverse perspectives and lived experiences of educational work.
Fitzgerald A, Parr G, Williams J. Fitzgerald A, et al. Among authors: parr g. Aust Educ Res. 2022;49(3):481-488. doi: 10.1007/s13384-022-00527-2. Epub 2022 Apr 20. Aust Educ Res. 2022. PMID: 35469321 Free PMC article. No abstract available.
A combination obturator.
Parr GR. Parr GR. J Prosthet Dent. 1979 Mar;41(3):329-30. doi: 10.1016/0022-3913(79)90018-0. J Prosthet Dent. 1979. PMID: 283233
The evolution of the obturator framework design.
Parr GR, Gardner LK. Parr GR, et al. J Prosthet Dent. 2003 Jun;89(6):608-10. doi: 10.1016/s0022-3913(03)00176-8. J Prosthet Dent. 2003. PMID: 12815356 Review.
Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia.
Jurczak W, Elmusharaf N, Fox CP, Townsend W, Paulovich AG, Whiteaker JR, Krantz F, Wun CC, Parr G, Sharma S, Munugalavadla V, Manwani R, Dean E, Munir T. Jurczak W, et al. Among authors: parr g. Ther Adv Hematol. 2023 May 30;14:20406207231173489. doi: 10.1177/20406207231173489. eCollection 2023. Ther Adv Hematol. 2023. PMID: 37273420 Free PMC article.
Phase 2 of the Norwich COVID-19 testing initiative: an evaluation.
Berger Gillam T, Chin J, Cossey S, Culley K, Davidson RK, Edwards DR, Gharbi K, Goodwin N, Hall N, Hitchcock M, Jupp OJ, Lipscombe J, Parr G, Shearer N, Smith R, Steel N. Berger Gillam T, et al. Among authors: parr g. J Public Health (Oxf). 2021 Dec 10;43(4):e749-e750. doi: 10.1093/pubmed/fdab124. J Public Health (Oxf). 2021. PMID: 33839796 Free PMC article. No abstract available.
Towards the safer use of medicines.
Asscher AW, Parr GD, Whitmarsh VB. Asscher AW, et al. Among authors: parr gd. BMJ. 1995 Oct 14;311(7011):1003-6. doi: 10.1136/bmj.311.7011.1003. BMJ. 1995. PMID: 7580589 Free PMC article.
A trust framework for digital food systems.
Brewer S, Pearson S, Maull R, Godsiff P, Frey JG, Zisman A, Parr G, McMillan A, Cameron S, Blackmore H, Manning L, Bidaut L. Brewer S, et al. Among authors: parr g. Nat Food. 2021 Aug;2(8):543-545. doi: 10.1038/s43016-021-00346-1. Nat Food. 2021. PMID: 37118166 No abstract available.
179 results